The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Chemical Medication in COVID-19 Market Research Report 2025

Global Chemical Medication in COVID-19 Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1928455

No of Pages : 93

Ask Your Query
Synopsis
According to China's clinical trials of COVID-19 treatment, the most clinically tested varieties are chemical drugs, especially chloroquine and antiviral drugs. Due to effective control, the proportion of clinical trials in China has been greatly reduced. Among the chemical drug clinical projects, chloroquine accounted for the largest proportion, followed by ritonavir、lopinavir and ridacive.
This report focuses on the investigation and analysis of chemical medication in COVID-19 and predicts the future market development of biopharmaceuticals under the influence of COVID-19.
The global Chemical Medication in COVID-19 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chemical Medication in COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Medication in COVID-19.
Report Scope
The Chemical Medication in COVID-19 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemical Medication in COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemical Medication in COVID-19 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
AbbVie
Johnson & Johnson
Pfizer
Mylan
Bayer
Zhejiang Hisun
CSPC Pharmaceutical Group
Reyoung Pharmaceutical
Sihuan Pharmaceutical
Hikma Pharmaceuticals
Rising Pharmaceutical
Sun Pharma
Shanghai Pharma
Guangzhou Baiyunshan Guanghua Pharmaceutical
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Segment by Type
Remedsivir
Ardidol
Favipivir
Lopinavir/ritonavir (LPV/r)
Chloroquine
Others
Segment by Application
COVID-19
Influenza
Malaria
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemical Medication in COVID-19 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical Medication in COVID-19 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Remedsivir
1.2.3 Ardidol
1.2.4 Favipivir
1.2.5 Lopinavir/ritonavir (LPV/r)
1.2.6 Chloroquine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chemical Medication in COVID-19 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical Medication in COVID-19 Market Perspective (2019-2030)
2.2 Chemical Medication in COVID-19 Growth Trends by Region
2.2.1 Global Chemical Medication in COVID-19 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chemical Medication in COVID-19 Historic Market Size by Region (2019-2024)
2.2.3 Chemical Medication in COVID-19 Forecasted Market Size by Region (2025-2030)
2.3 Chemical Medication in COVID-19 Market Dynamics
2.3.1 Chemical Medication in COVID-19 Industry Trends
2.3.2 Chemical Medication in COVID-19 Market Drivers
2.3.3 Chemical Medication in COVID-19 Market Challenges
2.3.4 Chemical Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Medication in COVID-19 Players by Revenue
3.1.1 Global Top Chemical Medication in COVID-19 Players by Revenue (2019-2024)
3.1.2 Global Chemical Medication in COVID-19 Revenue Market Share by Players (2019-2024)
3.2 Global Chemical Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemical Medication in COVID-19 Revenue
3.4 Global Chemical Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Chemical Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Medication in COVID-19 Revenue in 2023
3.5 Chemical Medication in COVID-19 Key Players Head office and Area Served
3.6 Key Players Chemical Medication in COVID-19 Product Solution and Service
3.7 Date of Enter into Chemical Medication in COVID-19 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Medication in COVID-19 Breakdown Data by Type
4.1 Global Chemical Medication in COVID-19 Historic Market Size by Type (2019-2024)
4.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2025-2030)
5 Chemical Medication in COVID-19 Breakdown Data by Application
5.1 Global Chemical Medication in COVID-19 Historic Market Size by Application (2019-2024)
5.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chemical Medication in COVID-19 Market Size (2019-2030)
6.2 North America Chemical Medication in COVID-19 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chemical Medication in COVID-19 Market Size by Country (2019-2024)
6.4 North America Chemical Medication in COVID-19 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical Medication in COVID-19 Market Size (2019-2030)
7.2 Europe Chemical Medication in COVID-19 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chemical Medication in COVID-19 Market Size by Country (2019-2024)
7.4 Europe Chemical Medication in COVID-19 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical Medication in COVID-19 Market Size (2019-2030)
8.2 Asia-Pacific Chemical Medication in COVID-19 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2019-2024)
8.4 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical Medication in COVID-19 Market Size (2019-2030)
9.2 Latin America Chemical Medication in COVID-19 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chemical Medication in COVID-19 Market Size by Country (2019-2024)
9.4 Latin America Chemical Medication in COVID-19 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Medication in COVID-19 Market Size (2019-2030)
10.2 Middle East & Africa Chemical Medication in COVID-19 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2019-2024)
10.4 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Chemical Medication in COVID-19 Introduction
11.1.4 Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Chemical Medication in COVID-19 Introduction
11.2.4 AbbVie Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.2.5 AbbVie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Chemical Medication in COVID-19 Introduction
11.3.4 Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Chemical Medication in COVID-19 Introduction
11.4.4 Pfizer Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Chemical Medication in COVID-19 Introduction
11.5.4 Mylan Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Chemical Medication in COVID-19 Introduction
11.6.4 Bayer Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Zhejiang Hisun
11.7.1 Zhejiang Hisun Company Detail
11.7.2 Zhejiang Hisun Business Overview
11.7.3 Zhejiang Hisun Chemical Medication in COVID-19 Introduction
11.7.4 Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.7.5 Zhejiang Hisun Recent Development
11.8 CSPC Pharmaceutical Group
11.8.1 CSPC Pharmaceutical Group Company Detail
11.8.2 CSPC Pharmaceutical Group Business Overview
11.8.3 CSPC Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.8.4 CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.8.5 CSPC Pharmaceutical Group Recent Development
11.9 Reyoung Pharmaceutical
11.9.1 Reyoung Pharmaceutical Company Detail
11.9.2 Reyoung Pharmaceutical Business Overview
11.9.3 Reyoung Pharmaceutical Chemical Medication in COVID-19 Introduction
11.9.4 Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.9.5 Reyoung Pharmaceutical Recent Development
11.10 Sihuan Pharmaceutical
11.10.1 Sihuan Pharmaceutical Company Detail
11.10.2 Sihuan Pharmaceutical Business Overview
11.10.3 Sihuan Pharmaceutical Chemical Medication in COVID-19 Introduction
11.10.4 Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.10.5 Sihuan Pharmaceutical Recent Development
11.11 Hikma Pharmaceuticals
11.11.1 Hikma Pharmaceuticals Company Detail
11.11.2 Hikma Pharmaceuticals Business Overview
11.11.3 Hikma Pharmaceuticals Chemical Medication in COVID-19 Introduction
11.11.4 Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.11.5 Hikma Pharmaceuticals Recent Development
11.12 Rising Pharmaceutical
11.12.1 Rising Pharmaceutical Company Detail
11.12.2 Rising Pharmaceutical Business Overview
11.12.3 Rising Pharmaceutical Chemical Medication in COVID-19 Introduction
11.12.4 Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.12.5 Rising Pharmaceutical Recent Development
11.13 Sun Pharma
11.13.1 Sun Pharma Company Detail
11.13.2 Sun Pharma Business Overview
11.13.3 Sun Pharma Chemical Medication in COVID-19 Introduction
11.13.4 Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.13.5 Sun Pharma Recent Development
11.14 Shanghai Pharma
11.14.1 Shanghai Pharma Company Detail
11.14.2 Shanghai Pharma Business Overview
11.14.3 Shanghai Pharma Chemical Medication in COVID-19 Introduction
11.14.4 Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.14.5 Shanghai Pharma Recent Development
11.15 Guangzhou Baiyunshan Guanghua Pharmaceutical
11.15.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Detail
11.15.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
11.15.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Introduction
11.15.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.15.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
11.16 KPC Group
11.16.1 KPC Group Company Detail
11.16.2 KPC Group Business Overview
11.16.3 KPC Group Chemical Medication in COVID-19 Introduction
11.16.4 KPC Group Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.16.5 KPC Group Recent Development
11.17 Jinghua Pharmaceutical Group
11.17.1 Jinghua Pharmaceutical Group Company Detail
11.17.2 Jinghua Pharmaceutical Group Business Overview
11.17.3 Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.17.4 Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.17.5 Jinghua Pharmaceutical Group Recent Development
11.18 Zhongsheng Pharma
11.18.1 Zhongsheng Pharma Company Detail
11.18.2 Zhongsheng Pharma Business Overview
11.18.3 Zhongsheng Pharma Chemical Medication in COVID-19 Introduction
11.18.4 Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.18.5 Zhongsheng Pharma Recent Development
11.19 North China Pharmaceutical Group
11.19.1 North China Pharmaceutical Group Company Detail
11.19.2 North China Pharmaceutical Group Business Overview
11.19.3 North China Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.19.4 North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024)
11.19.5 North China Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Chemical Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Remedsivir
Table 3. Key Players of Ardidol
Table 4. Key Players of Favipivir
Table 5. Key Players of Lopinavir/ritonavir (LPV/r)
Table 6. Key Players of Chloroquine
Table 7. Key Players of Others
Table 8. Global Chemical Medication in COVID-19 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Chemical Medication in COVID-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Chemical Medication in COVID-19 Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Chemical Medication in COVID-19 Market Share by Region (2019-2024)
Table 12. Global Chemical Medication in COVID-19 Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Chemical Medication in COVID-19 Market Share by Region (2025-2030)
Table 14. Chemical Medication in COVID-19 Market Trends
Table 15. Chemical Medication in COVID-19 Market Drivers
Table 16. Chemical Medication in COVID-19 Market Challenges
Table 17. Chemical Medication in COVID-19 Market Restraints
Table 18. Global Chemical Medication in COVID-19 Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Chemical Medication in COVID-19 Market Share by Players (2019-2024)
Table 20. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Medication in COVID-19 as of 2023)
Table 21. Ranking of Global Top Chemical Medication in COVID-19 Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Chemical Medication in COVID-19 Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chemical Medication in COVID-19 Product Solution and Service
Table 25. Date of Enter into Chemical Medication in COVID-19 Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chemical Medication in COVID-19 Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2019-2024)
Table 29. Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2025-2030)
Table 31. Global Chemical Medication in COVID-19 Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2019-2024)
Table 33. Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2025-2030)
Table 35. North America Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Chemical Medication in COVID-19 Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Chemical Medication in COVID-19 Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Chemical Medication in COVID-19 Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Chemical Medication in COVID-19 Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Chemical Medication in COVID-19 Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Chemical Medication in COVID-19 Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Chemical Medication in COVID-19 Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2025-2030) & (US$ Million)
Table 50. Gilead Sciences Company Detail
Table 51. Gilead Sciences Business Overview
Table 52. Gilead Sciences Chemical Medication in COVID-19 Product
Table 53. Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 54. Gilead Sciences Recent Development
Table 55. AbbVie Company Detail
Table 56. AbbVie Business Overview
Table 57. AbbVie Chemical Medication in COVID-19 Product
Table 58. AbbVie Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 59. AbbVie Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Chemical Medication in COVID-19 Product
Table 63. Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Chemical Medication in COVID-19 Product
Table 68. Pfizer Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Mylan Company Detail
Table 71. Mylan Business Overview
Table 72. Mylan Chemical Medication in COVID-19 Product
Table 73. Mylan Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 74. Mylan Recent Development
Table 75. Bayer Company Detail
Table 76. Bayer Business Overview
Table 77. Bayer Chemical Medication in COVID-19 Product
Table 78. Bayer Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 79. Bayer Recent Development
Table 80. Zhejiang Hisun Company Detail
Table 81. Zhejiang Hisun Business Overview
Table 82. Zhejiang Hisun Chemical Medication in COVID-19 Product
Table 83. Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 84. Zhejiang Hisun Recent Development
Table 85. CSPC Pharmaceutical Group Company Detail
Table 86. CSPC Pharmaceutical Group Business Overview
Table 87. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Product
Table 88. CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 89. CSPC Pharmaceutical Group Recent Development
Table 90. Reyoung Pharmaceutical Company Detail
Table 91. Reyoung Pharmaceutical Business Overview
Table 92. Reyoung Pharmaceutical Chemical Medication in COVID-19 Product
Table 93. Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 94. Reyoung Pharmaceutical Recent Development
Table 95. Sihuan Pharmaceutical Company Detail
Table 96. Sihuan Pharmaceutical Business Overview
Table 97. Sihuan Pharmaceutical Chemical Medication in COVID-19 Product
Table 98. Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 99. Sihuan Pharmaceutical Recent Development
Table 100. Hikma Pharmaceuticals Company Detail
Table 101. Hikma Pharmaceuticals Business Overview
Table 102. Hikma Pharmaceuticals Chemical Medication in COVID-19 Product
Table 103. Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 104. Hikma Pharmaceuticals Recent Development
Table 105. Rising Pharmaceutical Company Detail
Table 106. Rising Pharmaceutical Business Overview
Table 107. Rising Pharmaceutical Chemical Medication in COVID-19 Product
Table 108. Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 109. Rising Pharmaceutical Recent Development
Table 110. Sun Pharma Company Detail
Table 111. Sun Pharma Business Overview
Table 112. Sun Pharma Chemical Medication in COVID-19 Product
Table 113. Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 114. Sun Pharma Recent Development
Table 115. Shanghai Pharma Company Detail
Table 116. Shanghai Pharma Business Overview
Table 117. Shanghai Pharma Chemical Medication in COVID-19 Product
Table 118. Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 119. Shanghai Pharma Recent Development
Table 120. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Detail
Table 121. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
Table 122. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Product
Table 123. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 124. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 125. KPC Group Company Detail
Table 126. KPC Group Business Overview
Table 127. KPC Group Chemical Medication in COVID-19 Product
Table 128. KPC Group Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 129. KPC Group Recent Development
Table 130. Jinghua Pharmaceutical Group Company Detail
Table 131. Jinghua Pharmaceutical Group Business Overview
Table 132. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Product
Table 133. Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 134. Jinghua Pharmaceutical Group Recent Development
Table 135. Zhongsheng Pharma Company Detail
Table 136. Zhongsheng Pharma Business Overview
Table 137. Zhongsheng Pharma Chemical Medication in COVID-19 Product
Table 138. Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 139. Zhongsheng Pharma Recent Development
Table 140. North China Pharmaceutical Group Company Detail
Table 141. North China Pharmaceutical Group Business Overview
Table 142. North China Pharmaceutical Group Chemical Medication in COVID-19 Product
Table 143. North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2019-2024) & (US$ Million)
Table 144. North China Pharmaceutical Group Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemical Medication in COVID-19 Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chemical Medication in COVID-19 Market Share by Type: 2023 VS 2030
Figure 3. Remedsivir Features
Figure 4. Ardidol Features
Figure 5. Favipivir Features
Figure 6. Lopinavir/ritonavir (LPV/r) Features
Figure 7. Chloroquine Features
Figure 8. Others Features
Figure 9. Global Chemical Medication in COVID-19 Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Chemical Medication in COVID-19 Market Share by Application: 2023 VS 2030
Figure 11. COVID-19 Case Studies
Figure 12. Influenza Case Studies
Figure 13. Malaria Case Studies
Figure 14. Others Case Studies
Figure 15. Chemical Medication in COVID-19 Report Years Considered
Figure 16. Global Chemical Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Chemical Medication in COVID-19 Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Chemical Medication in COVID-19 Market Share by Region: 2023 VS 2030
Figure 19. Global Chemical Medication in COVID-19 Market Share by Players in 2023
Figure 20. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Medication in COVID-19 as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Chemical Medication in COVID-19 Revenue in 2023
Figure 22. North America Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Chemical Medication in COVID-19 Market Share by Country (2019-2030)
Figure 24. United States Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Chemical Medication in COVID-19 Market Share by Country (2019-2030)
Figure 28. Germany Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Chemical Medication in COVID-19 Market Share by Region (2019-2030)
Figure 36. China Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Chemical Medication in COVID-19 Market Share by Country (2019-2030)
Figure 44. Mexico Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Chemical Medication in COVID-19 Market Share by Country (2019-2030)
Figure 48. Turkey Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Chemical Medication in COVID-19 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Gilead Sciences Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 51. AbbVie Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 53. Pfizer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 54. Mylan Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 56. Zhejiang Hisun Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 57. CSPC Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 58. Reyoung Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 59. Sihuan Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 61. Rising Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 62. Sun Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 63. Shanghai Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 64. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 65. KPC Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 66. Jinghua Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 67. Zhongsheng Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 68. North China Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock